Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven in Active Variceal Bleeding with Advanced Cirrhosis
NCT00154492Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2004
- Primary completion
- Aug 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 2 trial of coagulation factor VIIa in Variceal bleeding, sponsored by Novo Nordisk. Started Apr 2004; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
Variceal bleeding
Beyond the preview
Go deeper on NCT00154492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154492.